<?xml version="1.0" encoding="UTF-8"?>
<p>In cell culture, remdesivir has broad-spectrum antiviral activity against several other RNA viruses, including arenaviruses
 <sup>
  <xref rid="bibr14-2048872620922790" ref-type="bibr">14</xref>
 </sup> and coronaviruses.
 <sup>
  <xref rid="bibr16-2048872620922790" ref-type="bibr">16</xref>
 </sup> It was previously shown that remdesivir can efficiently inhibit SARS-CoV-1 and MERS-CoV in cell culture, including in human airway epithelial cells.
 <sup>
  <xref rid="bibr16-2048872620922790" ref-type="bibr">16</xref>
 </sup> Remdesivir also demonstrated antiviral activity against SARS-CoV-1 and MERS-CoV in an animal model. In the MERS mouse model, remdesivir reduced lung viral loads and severe lung pathology.
 <sup>
  <xref rid="bibr17-2048872620922790" ref-type="bibr">17</xref>
 </sup> Very recently, it was shown that remdesivir is also active against SARS-CoV-2 in cells.
 <sup>
  <xref rid="bibr8-2048872620922790" ref-type="bibr">8</xref>
 </sup>
</p>
